187 related articles for article (PubMed ID: 12893741)
1. Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis.
Takeda K; Kishi H; Ma X; Yu ZX; Adelstein RS
Circ Res; 2003 Aug; 93(4):330-7. PubMed ID: 12893741
[TBL] [Abstract][Full Text] [Related]
2. Nonmuscle myosin II localizes to the Z-lines and intercalated discs of cardiac muscle and to the Z-lines of skeletal muscle.
Takeda K; Yu ZX; Qian S; Chin TK; Adelstein RS; Ferrans VJ
Cell Motil Cytoskeleton; 2000 May; 46(1):59-68. PubMed ID: 10842333
[TBL] [Abstract][Full Text] [Related]
3. Nonmuscle myosin II-B is required for normal development of the mouse heart.
Tullio AN; Accili D; Ferrans VJ; Yu ZX; Takeda K; Grinberg A; Westphal H; Preston YA; Adelstein RS
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12407-12. PubMed ID: 9356462
[TBL] [Abstract][Full Text] [Related]
4. Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.
Ma X; Jana SS; Conti MA; Kawamoto S; Claycomb WC; Adelstein RS
Mol Biol Cell; 2010 Nov; 21(22):3952-62. PubMed ID: 20861308
[TBL] [Abstract][Full Text] [Related]
5. Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.
Lu W; Seeholzer SH; Han M; Arnold AS; Serrano M; Garita B; Philp NJ; Farthing C; Steele P; Chen J; Linask KK
Dev Dyn; 2008 Dec; 237(12):3577-90. PubMed ID: 18697221
[TBL] [Abstract][Full Text] [Related]
6. Gene dosage affects the cardiac and brain phenotype in nonmuscle myosin II-B-depleted mice.
Uren D; Hwang HK; Hara Y; Takeda K; Kawamoto S; Tullio AN; Yu ZX; Ferrans VJ; Tresser N; Grinberg A; Preston YA; Adelstein RS
J Clin Invest; 2000 Mar; 105(5):663-71. PubMed ID: 10712438
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous expression of nonmuscle myosin heavy chain-B in mesangial cells of patients with Gitelman's syndrome.
Sakumura T; Umemoto S; Fujii Z; Fujii K; Kawata Y; Minami M; Matsuzaki M
Clin Nephrol; 2001 Mar; 55(3):238-42. PubMed ID: 11316245
[TBL] [Abstract][Full Text] [Related]
8. Expression of non-muscle myosin heavy chain in rat heart after immunosuppressive treatment.
Rezzani R; Pompili E; Agostini C; Buffoli B; Bonomini F; Nori S; Fumagalli L; Bianchi R
Int Immunopharmacol; 2006 Jun; 6(6):962-7. PubMed ID: 16644482
[TBL] [Abstract][Full Text] [Related]
9. Replacement of nonmuscle myosin II-B with II-A rescues brain but not cardiac defects in mice.
Bao J; Ma X; Liu C; Adelstein RS
J Biol Chem; 2007 Jul; 282(30):22102-11. PubMed ID: 17519229
[TBL] [Abstract][Full Text] [Related]
10. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
[TBL] [Abstract][Full Text] [Related]
11. Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain.
Obungu VH; Lee Burns A; Agarwal SK; Chandrasekharapa SC; Adelstein RS; Marx SJ
Oncogene; 2003 Sep; 22(41):6347-58. PubMed ID: 14508515
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
13. Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts.
Costa AD
Cardiovasc Res; 2008 Apr; 78(1):1-2. PubMed ID: 18250142
[No Abstract] [Full Text] [Related]
14. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development.
Li F; Wang X; Capasso JM; Gerdes AM
J Mol Cell Cardiol; 1996 Aug; 28(8):1737-46. PubMed ID: 8877783
[TBL] [Abstract][Full Text] [Related]
15. Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.
Kim KY; Kovács M; Kawamoto S; Sellers JR; Adelstein RS
J Biol Chem; 2005 Jun; 280(24):22769-75. PubMed ID: 15845534
[TBL] [Abstract][Full Text] [Related]
16. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
Li Y; Friedmann DR; Mhatre AN; Lalwani AK
Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
[TBL] [Abstract][Full Text] [Related]
17. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
18. NFATc3 and NFATc4 are required for cardiac development and mitochondrial function.
Bushdid PB; Osinska H; Waclaw RR; Molkentin JD; Yutzey KE
Circ Res; 2003 Jun; 92(12):1305-13. PubMed ID: 12750314
[TBL] [Abstract][Full Text] [Related]
19. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia.
Tavener SA; Long EM; Robbins SM; McRae KM; Van Remmen H; Kubes P
Circ Res; 2004 Oct; 95(7):700-7. PubMed ID: 15358664
[TBL] [Abstract][Full Text] [Related]
20. Conditional expression of a truncated fragment of nonmuscle myosin II-A alters cell shape but not cytokinesis in HeLa cells.
Wei Q; Adelstein RS
Mol Biol Cell; 2000 Oct; 11(10):3617-27. PubMed ID: 11029059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
